Global and Region Onychomycosis Drugs Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Onychomycosis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Onychomycosis Drugsmarket, defines the market attractiveness level of Onychomycosis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Onychomycosis Drugs industry, describes the types of Onychomycosis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Onychomycosis Drugs market and the development prospects and opportunities of Onychomycosis Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Onychomycosis Drugs market in Chapter 13.

    By Player:

    • Qilu Pharmaceutical

    • Valeant Pharma

    • Letai

    • GSK

    • Johnson and Johnson

    • Galderma

    • Novartis

    • Kaken Pharmaceutical

    • Pfizer

    • Xiuzheng Pharmaceutical

    By Type:

    • Oral Drugs

    • Topical Drugs

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Onychomycosis Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Onychomycosis Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Onychomycosis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Onychomycosis Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Onychomycosis Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Onychomycosis Drugs Consumption (2017-2022)

    • 7.2 United States Onychomycosis Drugs Consumption (2017-2022)

    • 7.3 Europe Onychomycosis Drugs Consumption (2017-2022)

    • 7.4 China Onychomycosis Drugs Consumption (2017-2022)

    • 7.5 Japan Onychomycosis Drugs Consumption (2017-2022)

    • 7.6 India Onychomycosis Drugs Consumption (2017-2022)

    • 7.7 South Korea Onychomycosis Drugs Consumption (2017-2022)

    8 Region and Country-wise Onychomycosis Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Onychomycosis Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Onychomycosis Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Onychomycosis Drugs Consumption Forecast (2022-2028)

    • 8.4 China Onychomycosis Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Onychomycosis Drugs Consumption Forecast (2022-2028)

    • 8.6 India Onychomycosis Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Onychomycosis Drugs Consumption Forecast (2022-2028)

    9 Global Onychomycosis Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Onychomycosis Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Topical Drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Onychomycosis Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Onychomycosis Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Onychomycosis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oral Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Topical Drugs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Onychomycosis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Onychomycosis Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Onychomycosis Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Onychomycosis Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Onychomycosis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Onychomycosis Drugs Market Competitive Analysis

    • 14.1 Qilu Pharmaceutical

      • 14.1.1 Qilu Pharmaceutical Company Details

      • 14.1.2 Qilu Pharmaceutical Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Qilu Pharmaceutical Onychomycosis Drugs Product and Service

    • 14.2 Valeant Pharma

      • 14.2.1 Valeant Pharma Company Details

      • 14.2.2 Valeant Pharma Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Valeant Pharma Onychomycosis Drugs Product and Service

    • 14.3 Letai

      • 14.3.1 Letai Company Details

      • 14.3.2 Letai Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Letai Onychomycosis Drugs Product and Service

    • 14.4 GSK

      • 14.4.1 GSK Company Details

      • 14.4.2 GSK Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GSK Onychomycosis Drugs Product and Service

    • 14.5 Johnson and Johnson

      • 14.5.1 Johnson and Johnson Company Details

      • 14.5.2 Johnson and Johnson Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Johnson and Johnson Onychomycosis Drugs Product and Service

    • 14.6 Galderma

      • 14.6.1 Galderma Company Details

      • 14.6.2 Galderma Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Galderma Onychomycosis Drugs Product and Service

    • 14.7 Novartis

      • 14.7.1 Novartis Company Details

      • 14.7.2 Novartis Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis Onychomycosis Drugs Product and Service

    • 14.8 Kaken Pharmaceutical

      • 14.8.1 Kaken Pharmaceutical Company Details

      • 14.8.2 Kaken Pharmaceutical Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Kaken Pharmaceutical Onychomycosis Drugs Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Onychomycosis Drugs Product and Service

    • 14.10 Xiuzheng Pharmaceutical

      • 14.10.1 Xiuzheng Pharmaceutical Company Details

      • 14.10.2 Xiuzheng Pharmaceutical Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Xiuzheng Pharmaceutical Onychomycosis Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Onychomycosis Drugs

    • Figure Onychomycosis Drugs Picture

    • Table Global Onychomycosis Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Onychomycosis Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Onychomycosis Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Onychomycosis Drugs Consumption by Country (2017-2022)

    • Figure United States Onychomycosis Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Onychomycosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Onychomycosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Onychomycosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Onychomycosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Onychomycosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Onychomycosis Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Onychomycosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Onychomycosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Onychomycosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Onychomycosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Onychomycosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Onychomycosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Topical Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Topical Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Onychomycosis Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Onychomycosis Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Qilu Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Qilu Pharmaceutical Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qilu Pharmaceutical Onychomycosis Drugs Product and Service

    • Table Valeant Pharma (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharma Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharma Onychomycosis Drugs Product and Service

    • Table Letai (Foundation Year, Company Profile and etc.)

    • Table Letai Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Letai Onychomycosis Drugs Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Onychomycosis Drugs Product and Service

    • Table Johnson and Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson and Johnson Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson Onychomycosis Drugs Product and Service

    • Table Galderma (Foundation Year, Company Profile and etc.)

    • Table Galderma Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galderma Onychomycosis Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Onychomycosis Drugs Product and Service

    • Table Kaken Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Kaken Pharmaceutical Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kaken Pharmaceutical Onychomycosis Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Onychomycosis Drugs Product and Service

    • Table Xiuzheng Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Xiuzheng Pharmaceutical Onychomycosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Xiuzheng Pharmaceutical Onychomycosis Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.